Role of cardiac renin-angiotensin system in the development of pressure-overload left ventricular hypertrophy in rats with abdominal aortic constriction

Molecular and Cellular Biochemistry

Volumn 155, Issue 1, 1996, Pages 1-11

  Reddy, Doodipala S ^a   Singh, Manjeet ^a   Ghosh, Sujata ^b   Ganguly, N K ^b  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Angiotensin II; Captopril; Hydralazine; Left ventricular hypertrophy; Myosin isoforms

Indexed keywords

BIOCHEMICAL MARKER; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA; HYDRALAZINE; MYOSIN; PROTEIN; RNA; VASODILATOR AGENT;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEART LEFT VENTRICLE HYPERTROPHY; HEMODYNAMICS; MEAN ARTERIAL PRESSURE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA, ABDOMINAL; BLOOD PRESSURE; BODY WEIGHT; CAPTOPRIL; CAROTID ARTERIES; DNA; FEMALE; HEART; HEART VENTRICLES; HEMODYNAMIC PROCESSES; HYDRALAZINE; HYPERTROPHY, LEFT VENTRICULAR; MYOCARDIUM; MYOSIN HEAVY CHAINS; ORGAN SIZE; RATS; RATS, INBRED STRAINS; REFERENCE VALUES; RENIN-ANGIOTENSIN SYSTEM; RNA; TIME FACTORS; VASODILATOR AGENTS;

ANIMALIA;

EID: 0030030274     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00714327     Document Type: Article

References (36)

1. Lindpaintner K, Ganten D: The Cardiac renin-angiotensm system: An appraisal of present experimental and clinical evidence. Circ Res 68: 905-21, 1991
2. Pfeffer JM, Pfeffer MA, Mirsky L, Braunwald E: Regression of LVH and prevention of LV dysfunction by captopril in the spontaneously hypertensive rats. Proc Natl Acad Sci USA 79: 3310-14, 1982
3. Re RN: The cellular biology of angiotensin: Paracrine, autocrine and intracrine actions in cardiovascular tissues. J Mol Cell Cardiol 21 (Suppl. V): 63-69, 1989
4. Baker KM, Booz GW, Dostal DE: Cardic actions of angiotensin II: Role of an intracardiac renin-angiotensin system. Annu Rev Physiol 54: 227-41, 1992
5. Sen S, Tarazi RC, Khairallah PA, Bumpus FM: Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res 35: 775-81, 1974
6. Linz W, Schoelkens BA, Ganten D: Converting enzyme inhibition specifically prevents the development and induces the regression of cardiac hypertrophy in rats. Clin Exp Hypertens 11: 1325-35, 1989
7. Khairallah PA, Kanabus J: Angiotensin and myocardial protein synthesis. In: R.D. Tarazi, J.B. Dunbar (eds). Perspectives in Cardiovascular Research. Raven Press, New York, 1983: 8, pp-337-47
8. Baker KM: Cardiac actions of angiotensin. J Vasc Med Biol 3: 30-37, 1991
9. Beinlich CJ, White GJ, Baker KM, Morgan HE: Angiotensin-II and left ventricular growth in newborn pig heart J Mol Cell Cardiol 23: 1031-38, 1991
10. Baker KM, Aceto JF: Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol 259: H610-18, 1990
11. 1 receptor subtype. Circ Res 73: 413-23, 1993
12. 1) angiotengin II receptor-mediated stimulation of protein synthesis in chick heart cells. Am J Physiol 258: H806-13, 1990
13. Sadoshima J, Izumo S: Signal transduction pathways of angiotensin II induced c-fos gene expression in cardiac myocytes in vitro: Roles of phospholipid derived second messengers. Circ Res 73: 424-38, 1993
14. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apsutein CS, Lorell BH: Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility, and relaxation. J Clin Invest 86: 1916-20, 1991
15. Baker KM, Chemin MI, Wixson SK, Aceto JF: Renin-angiotensin system involvement in pressure overload cardiac hypertrophy. Am J Physiol 259: H324-32, 1990
16. Kromer EP, Riegger GAP: Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat Am J Cardiol 62: 161-63, 1988
17. Kromer EP, Elsner X, Riegger GAJ: Role of neurohumoral systems for pressure induced left ventricular hypertrophy in experimental supravalvular aortic stenosis in rats. J Hypertens 4: 521-24, 1991
18. Zierhut W, Zimmer HG, Gerdes AM: Effect of angiotensin converting inhibition on pressure-induced left ventricular hypertrophy in rats. Circ Res 69: 609-17, 1991
19. Ruzika M, Yuan B, Harmsen E, Leenan FHH: The renin angiotensin system and volume overload-induced cardiac hypertrophy in rats. Circulation 87: 921-930, 1993
20. Urata H, Healy, B, Stewart RW, Bumpus FM, Husain A: Angiotensin II forming pathways in normal and failing human hearts. Circ Res 66: 883-90, 1990
21. Kohya T, Kimura SK, Myerburg RJ, Bassett AL: Susceptibility of hypertrophied rat hearts to ventricular fibrillation during acute ischemia. J Mol Cell Cardiol 20: 159-68, 1988
22. Leenan FHH, Prowse S: Time-course of changed hypertrophy and pressor mechanisms in two-kidney, one clip hypertensive rats during treatment with minoxidil, enalapril or after uninephrectomy. J Hypertens 5: 73-83, 1987
23. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ: Protein measurement with the Folin-Phenol reagent J Biol Chem 193: 265-75, 1951
24. Burton RJ A study of the conditions and mechanism of the diphenylamine reaction for the colorometric estimation of deoxyribonucleic acid, Biochem J 62: 315-22, 1956
25. Richards GM: Modifications of the diphenylamine reaction giving increased sensitivity and simplicity in the estimation of DNA. Anal Biochem 57: 369-76, 1974
26. Chomozynski P, Sacchi N: A single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-59, 1987
27. Esser KA, Boluyt MO, White TP: Separation of cardiac myosin heavy chains by gradient SDS-PAGE. Am J Physiol 255: H659-63, 1988
28. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature Lond 227: 680-85, 1970
29. Chopra K, Singh M, Kaul N, Ganguly NK: Oxygen free radicals and protective effect of captopril on myocardial infarct size. Arch Int Pharmacodyn 322: 55-65, 1993
30. Clozel J-P, Saunier C, Harteman D, Fischli W: Effects of cilazapril a novel angiotensin converting enzyme inhibitor, on the structure of pulmonary arteries of rats exposed to chronic hypoxia. J Cardiovasc Pharmacol 17: 36-40, 1991
31. Kellet R, Gales AC, Fraser-Rae L, Jackson C, Richard D: Factors other than renin-angiotensin-aldosterone system (RAAS) are important in controlling left ventricular hypertrophy (Abstr.). J Mol Cell Cardiol 25 (Suppl. III): S-52, 1993
32. Msutomo, Hata T, Yanaga T: Effects of ACE inhibitor on regression of cardiac hypertrophy (Abstr.). J Mol Cell Cardiol 25 (Suppl. II): S34, 1993
33. Brilk CG, Pick R, Tan LB, Janicki JS, Weber KT: Remodelling of rat right and left ventricles in experimental hypertension. Circ Res 67: 1355-64, 1990
34. Brilla CG, Weber KT: Myokardifibrose bei art Hypertonie: Regression via Geweb-RAS-Hemmung (Abstr.). Z Kardiol 80 (Suppl. III): 164} 1991
35. Nadal-Ginard B, Mahdavi V: General principles of Cardiovascular Cellular and Molecular Biology, In: E Braunwald (ed.). Heart Disease. WB Saunders Company, Philadelphia, 1992, pp 1602-21
36. Oka N, Nakata M, Tanaka M, Sumida E, Chiba M, KogaY, Toshima H: Role of adrenergic and angiotensin systems in the development of pressure-overload cardiac hypertrophy in rats with abdominal aortic constriction (Abstr.). J Mol Cell Cardiol 25 (Suppl. II): S33, 1993